Business
Movano Health Provides Business Update and Reports Fourth Quarter 2022 Financial Results
Conference call begins at 9:00 a.m. Pacific time today PLEASANTON, Calif., March 20, 2023 /PRNewswire/ -- Today, Movano Health (Nasdaq: MOVE), a
About this update from Corvex, Inc.
[{"type":"text","content":"Conference call begins at 9:00 a.m. Pacific time today\nPLEASANTON, Calif., March 20, 2023 /PRNewswire/ -- Today, Movano Health (Nasdaq: MOVE), a purpose-driven healthcare solutions company at the intersection of medical and consumer devices and makers of the Evie Ring, reported financial results for the three months and year ending December 31, 2022 and provided a business update.\n\n \n \n \n \n \n \n\n \nKey highlights from the fourth quarter and recent weeks include:\nMovano Health continues to progress toward the summer 2023 launch of its first commercial product, the Evie Ring.Given the strong demand in its initial beta, the Company announced a second beta program with a new slate of partners, among which are a global athletic apparel company and two additional leading global medical device companies.Movano Health plans to file its first 510(k) submission for FDA clearance of the Evie Ring's heart rate and SpO2 data this spring following a successful hypoxia pivotal trial in Q4 of 2022.The Company plans to commence the first blood pressure and glucose clinical studies using its proprietary single chip technology imminently.Movano Health has recently been issued nine new U.S. patents, including multiple foundational patents that protect the Company's unique method, system and algorithms used for measuring blood pressure and glucose non-invasively and without a cuff.\"It's an exciting time at Movano Health as we're about to launch our first product, the Evie Ring, transitioning us from a pre- to revenue-generating company and opening the door to a massive opportunity for product partnerships,\" said John Mastrototaro, CEO of Movano Health. \"With the Evie Ring and our future pipeline of devices, we're forging new territory by developing products positioned at the intersection of medtech and consumer devices, a market opportunity we believe is worth $50 billion in the United States alone.\"\nMovano Health details more information on the key highlights from the fourth quarter and recent weeks below:\nMovano Health continues to progress toward the summer 2023 launch of its first commercial product, the Evie Ring. After unveiling the ring at the Consumer Electronics Show in early 2023, the Evie Ring won a total of 11 Best of CES awards from premium publications including CNN, USA Today, Wired and Digital Trends, which highlighte...